231 related articles for article (PubMed ID: 418405)
21. D2- but not D3-dopamine receptors detected in the anterior pituitary.
Titeler M; Van Loon GR; Seeman P; Brown GM
Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
[TBL] [Abstract][Full Text] [Related]
22. [3H]Apomorphine binding to a GTP-sensitive dopaminergic site in bovine anterior pituitary gland.
Di Paolo T; Gagné B; Poyet P; Labrie F
Can J Biochem; 1982 Nov; 60(11):1043-9. PubMed ID: 7172091
[TBL] [Abstract][Full Text] [Related]
23. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
Whitaker PM; Seeman P
Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
[TBL] [Abstract][Full Text] [Related]
24. 3H-Apomorphine interactions with dopamine receptors in calf brain.
Thal L; Creese I; Snyder SH
Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
[TBL] [Abstract][Full Text] [Related]
25. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
26. Development of specificity and stereoselectivity of rat brain dopamine receptors.
Miller JC; Friedhoff AJ
Int J Dev Neurosci; 1986; 4(1):21-6. PubMed ID: 2458672
[TBL] [Abstract][Full Text] [Related]
27. D2 dopamine receptors in calf globus pallidus: agonist high- and low-affinity sites not regulated by guanine nucleotide.
De Keyser J; De Backer JP; Convents A; Ebinger G; Vauquelin G
J Neurochem; 1985 Sep; 45(3):977-9. PubMed ID: 2411862
[TBL] [Abstract][Full Text] [Related]
28. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
29. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
30. Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
Rosenblatt JE; Shore D; Neckers LM; Perlow MJ; Freed WJ; Wyatt RJ
Eur J Pharmacol; 1979 Dec; 60(4):387-8. PubMed ID: 93551
[No Abstract] [Full Text] [Related]
31. Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
Bacopoulos NG; Ware PL
Life Sci; 1980 Dec 22-29; 27(25-26):2489-94. PubMed ID: 6163938
[No Abstract] [Full Text] [Related]
32. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
Weller ME; Rose S; Jenner P; Marsden CD
Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
[TBL] [Abstract][Full Text] [Related]
33. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
Clement-Cormier YC; George RJ
J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
[No Abstract] [Full Text] [Related]
34. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
[TBL] [Abstract][Full Text] [Related]
35. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
Bacopoulos NG
Biochem Pharmacol; 1982 Oct; 31(19):3085-91. PubMed ID: 7150335
[TBL] [Abstract][Full Text] [Related]
36. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
Varmuza S; Mishra RK
Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
[No Abstract] [Full Text] [Related]
37. Selective labeling of apomorphine receptors by 3H-LSD.
Whitaker PM; Seeman P
Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
[TBL] [Abstract][Full Text] [Related]
38. Neuroleptic receptors: stereoselectivity for neuroleptic enantiomers.
Seeman P; Westman K; Protiva M; Jílek J; Jain PC; Saxena AK; Anand N; Humber L; Philipp A
Eur J Pharmacol; 1979 Jun; 56(3):247-51. PubMed ID: 38971
[TBL] [Abstract][Full Text] [Related]
39. Dopamine receptors in the central nervous system.
Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
[TBL] [Abstract][Full Text] [Related]
40. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
Battaglia G; Titeler M
Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
